Lv7
4988 积分 2021-11-23 加入
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
21小时前
已完结
Overview of Extracellular Matrix
6天前
已完结
Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment
13天前
已关闭
Long-Chain Fatty Acid Redistribution Induced by SLC27A2 Deficiency Facilitates Hypoxic Adaptation and Immunosuppression in Hepatocellular Carcinoma
1个月前
已完结
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
1个月前
已完结
Aryl hydrocarbon receptor ligands drive pancreatic cancer initiation and progression through pro-tumorigenic T cell polarization
3个月前
已完结
A Pan-Cancer Analysis to Provide Insight into the Immunological Role and Prognostic Value of HTRA3
4个月前
已完结
皖公网安备34019202002308
